SAHPRA approves third dose of Pfizer COVID-19 vaccine
The South African Health Products Authority (SAHPRA) has approved a third (booster) dose of the
J&J vaccine recipients will be informed of possibility of blood clots developing
The South African Health Products Authority (SAHPRA) says recipients of the Johnson and Johnson